Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

Por Hoffmann, Katrin, Ganten, Tom, Gotthardtp, Daniel, Radeleff, Boris, Settmacher, Utz, Kollmar, Otto, Nadalin, Silvio, Karapanagiotou-Schenkel, Irini, von Kalle, Christof, Jäger, Dirk, Büchler, Markus W, Schemmer, Peter
Publicado no BMC Cancer (2015)